BDSX · Biodesix Inc · Executive Compensation

$26.97 +0.93 (+3.55%) At close · Sep 11

Market Cap

$284.67M

10.55M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Hutton	President and Chief Executive Officer	$643,404	—	$356,849	$524,437	$710,280	$3,500	$2,238,470
Kieran O'Kane	Chief Commercial Officer	$443,048	—	$108,206	$159,023	$293,489	$3,526	$1,007,292
Robin Harper Cowie	Chief Financial Officer, Secretary and Treasurer	$443,366	—	$108,206	$159,023	$244,707	$6,699	$962,001

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Hutton	President and Chief Executive Officer	$588,858	—	$419,144	$852,017	$223,604	$1,250	$2,084,873
Kieran O'Kane	Chief Commercial Officer	$401,554	—	$128,118	$233,451	$137,522	—	$900,645
Robin Harper Cowie	Chief Financial Officer, Secretary and Treasurer	$405,881	—	$128,118	$224,690	$115,597	$1,250	$875,536

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Hutton	President and Chief Executive Officer	$515,000	—	$1,442,001	$233,622	$98,058	$1,865	$2,290,546
Robin Harper Cowie	Chief Financial Officer, Secretary and Treasurer	$355,000	—	$372,751	$81,319	$33,797	$1,500	$844,367
Kieran O'Kane	Chief Commercial Officer	$335,000	—	$234,499	$45,555	$57,407	$205	$672,666

Executive changes

Person	Role	Change	Effective	Filed
Jack Schuler	director of the Board	Resigned	2025-05-20	2025-04-17
Charles Watts, M.D.	director of the Board	Resigned	2025-05-20	2025-04-17

Key facts CIK 1439725 CUSIP 09075X207 13F (30d) 24 filings 24 filers Visit website Investor relations